|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Myocardial Ischemia | |||||
| Reperfusion Injury | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Ischemia | |||||
| 3 | More general conditions related to this trial | ||||
| Cardiovascular Diseases | |||||
| Heart Diseases | |||||
| Pathologic Processes | |||||
| Postoperative Complications | |||||
| Vascular Diseases | |||||
| 4 | Interventions listed in this trial | ||||
| (MC-1) Pyridoxal 5'-phosphate | |||||
| 5 | Additional drug interventions recognized in this trial | ||||
| Pyridoxal Phosphate | |||||
| 6 | More general drug interventions related to this trial | ||||
| Growth Substances | |||||
| Micronutrients | |||||
| Pharmacologic Actions | |||||
| Physiological Effects of Drugs | |||||
| Vitamin B Complex | |||||
| Vitamins | |||||
| 7 | Sponsors listed in this trial | ||||
| Medicure | |||||